Our Institutes

  • Slideshow Slides (Drop Images In This Box)
    • Ipd-llc
      5
      appear
    • Idd_clean
      5
      appear
    • Iba_llcxsm
      5
      appear
    • Ipd-ch_logo
      5
      appear

  • IDD is a drug discovery company focused on the rapid translation of early molecular targets into programs whose goal is novel, patentable compounds. IDD partners with universities for developing novel, early stage drug discovery targets into high value, preclinical proof of concept assets to be licensed to pharmaceutical companies worldwide.

    As a leading developer of customized bioanalytical assay methods for the healthcare industry, IBA has the research expertise to convert an early molecular target into a viable diagnostic test either as a stand-alone screen or as a diagnostic paired with its target-related therapeutic agent.